GSK Asks Again For Dismissal Of Wellbutrin IP Claims
By Shannon Henson ( April 15, 2010, 1:49 PM EDT) -- GlaxoSmithKline PLC has asked a judge to reconsider its request to dismiss direct purchaser claims in a class action over the drugmaker's alleged filing of baseless patent suits to delay generic competition with antidepressant Wellbutrin SR....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.